Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  183 results for ""Abatacept""

Your Filters

Publisher : wiley
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

CD4 + CD8α low T Cell Clonal Expansion Dependent on Costimulation in Patients With Rheumatoid Arthritis.

  • Authors : Beck F; Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany.; Nguyen P

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/immunology ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/genetics

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Dec; Vol. 76 (12), pp. 1719-1729. Date of Electronic Publication: 2024 Sep 04.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Model-Based Selection and Recommendation for Subcutaneous Abatacept Dose in Patients With Polyarticular Juvenile Idiopathic Arthritis.

Subjects: Abatacept/Abatacept/Abatacept/*pharmacokinetics ; Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*pharmacokinetics

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2021 May; Vol. 61 (5), pp. 688-699. Date of Electronic Publication: 2021 Jan 18.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Linking process indicators and clinical/safety outcomes to assess the effectiveness of abatacept (ORENCIA) patient alert cards in patients with rheumatoid arthritis.

  • Authors : Artime E; Epidemiology & Risk Management, OXON Epidemiology, Madrid, Spain.; Kahlon R

Subjects: Health Knowledge, Attitudes, Practice* ; Patient Education as Topic* ; Reminder Systems*

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Jun; Vol. 29 (6), pp. 664-674. Date of Electronic Publication: 2020 May 12.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Scleroderma, Diffuse/Scleroderma, Diffuse/Scleroderma, Diffuse/*drug therapy ; Tumor Necrosis Factor Inhibitors/Tumor Necrosis Factor Inhibitors/Tumor Necrosis Factor Inhibitors/*therapeutic use

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2020 Jan; Vol. 72 (1), pp. 125-136. Date of Electronic Publication: 2019 Dec 10.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial.

  • Authors : Grøn KL; Rigshospitalet Glostrup, Glostrup, Denmark, and University of Copenhagen, Copenhagen, Denmark.; Glintborg B

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2019 Dec; Vol. 71 (12), pp. 1997-2004.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Population Pharmacokinetics and Exposure-Response Relationship of Intravenous and Subcutaneous Abatacept in Patients With Rheumatoid Arthritis.

  • Authors : Li X; Bristol-Myers Squibb, Princeton, NJ, USA.; Roy A

Subjects: Abatacept/Abatacept/Abatacept/*administration & dosage ; Abatacept/Abatacept/Abatacept/*pharmacokinetics ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*administration & dosage

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2019 Feb; Vol. 59 (2), pp. 245-257. Date of Electronic Publication: 2018 Sep 19.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.

Subjects: Abatacept/Abatacept/Abatacept/*administration & dosage ; Arthritis, Juvenile/Arthritis, Juvenile/Arthritis, Juvenile/*drug therapy ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*administration & dosage

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2018 Jul; Vol. 70 (7), pp. 1144-1154. Date of Electronic Publication: 2018 May 20.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.

  • Authors : Verstappen GM; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Meiners PM

Subjects: Abatacept/Abatacept/Abatacept/*pharmacology ; B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*drug effects ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*pharmacology

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2017 Sep; Vol. 69 (9), pp. 1850-1861. Date of Electronic Publication: 2017 Aug 13.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Giant Cell Arteritis/Giant Cell Arteritis/Giant Cell Arteritis/*drug therapy; Aged

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2017 Apr; Vol. 69 (4), pp. 837-845. Date of Electronic Publication: 2017 Mar 03.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Takayasu Arteritis/Takayasu Arteritis/Takayasu Arteritis/*drug therapy; Adolescent

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2017 Apr; Vol. 69 (4), pp. 846-853. Date of Electronic Publication: 2017 Mar 08.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  183 results for ""Abatacept""